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Introduction
Striated muscle contraction is built on an exquisitely regulated 
actin cytoskeleton, where actin isoforms sort into distinct, non-
overlapping compartments. The thin filaments of sarcomeres 
consist of skeletal muscle -actin (sk-actin), whereas extrasar-
comeric membrane compartments contain cytoplasmic -actin 
(cyto-actin; Craig and Pardo, 1983; Pardo et al., 1983; Otey 
et al., 1988; Rybakova et al., 2000). The lengths of sk-actin 
thin filaments are determined by sk-actin monomer exchange 
at pointed ends, which is in turn regulated by tropomodulins 
(Tmods), a family of tropomyosin (Tm)-binding and pointed 
end–capping proteins (Gregorio et al., 1995; Littlefield et al., 
2001; Littlefield and Fowler, 2008). In contrast, it is unknown 
whether Tmods regulate the lengths, stability, and/or organ-
ization of cyto-actin filaments, which are proposed to fortify the 
sarcolemma through their interactions with dystrophin and   
2-spectrin  at  costameres  (Craig  and  Pardo,  1983;  Porter   
et al., 1992, 1997; Renley et al., 1998; Rybakova et al., 2000;   
Williams et al., 2001). cyto-Actin is dispensable for skeletal 
muscle development, but its absence can produce muscle weak-
ness, indicating that cyto-actin plays a role in muscle mechani-
cal performance (Sonnemann et al., 2006; Belyantseva et al., 
2009). Surprisingly, cyto-actin–deficient muscles do not exhibit 
sarcolemmal defects, leaving the functional role of cyto-actin in 
muscle membranes uncertain (Sonnemann et al., 2006). How-
ever, up to 10-fold up-regulation of cyto-actin has been observed 
in various animal models of muscular dystrophy, including 
dystrophin-deficient mdx mice, -sarcoglycan–null mice, and 
golden retriever muscular dystrophy (Hanft et al., 2006, 2007). 
Thus, the importance of cyto-actin under pathological condi-
tions suggests possible functions for cyto-actin in the structural 
biology of other striated muscle membranes such as the sarco-
plasmic reticulum (SR).
Four Tmod isoforms could potentially regulate extrasarco-
meric cyto-actin organization in skeletal muscle. Tmod1 is found 
predominantly in terminally differentiated postmitotic cells (such 
as erythrocytes, lens fiber cells, neurons, and striated muscle), 
T
he  sarcoplasmic  reticulum  (SR)  serves  as  the   
Ca
2+ reservoir for muscle contraction. Tropomodu-
lins (Tmods) cap filamentous actin (F-actin) pointed 
ends,  bind  tropomyosins  (Tms),  and  regulate  F-actin 
organization. In this paper, we use a genetic targeting 
approach to examine the effect of Tmod1 deletion on the 
organization of cytoplasmic -actin (cyto-actin) in the SR 
of skeletal muscle. In wild-type muscle fibers, cyto-actin 
and Tmod3 defined an SR microdomain that was distinct 
from another Z line–flanking SR microdomain containing 
Tmod1 and Tmod4. The cyto-actin/Tmod3 microdomain 
contained an M line complex composed of small ankyrin 
1.5 (sAnk1.5), cyto-actin, Tmod3, Tm4, and Tm5NM1. 
Tmod1 deletion caused Tmod3 to leave its SR compart-
ment, leading to mislocalization and destabilization of the 
Tmod3–cyto-actin–sAnk1.5 complex. This was accompa-
nied by SR morphological defects, impaired Ca
2+ release, 
and an age-dependent increase in sarcomere misalign-
ment. Thus, Tmod3 regulates SR-associated cyto-actin 
architecture, mechanically stabilizes the SR via a novel 
cytoskeletal linkage to sAnk1.5, and maintains the align-
ment of adjacent myofibrils.
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the organization of cyto-actin via binding to sAnk1.5, thereby 
providing SR stabilization, extrasarcomeric cytoskeletal con-
nectivity, and a novel cytoskeletal linkage that facilitates lateral 
force transmission across muscle fibers.
Results
A cytoskeleton containing cyto-actin, 
Tmods, and spectrin localizes to 
extrasarcomeric compartments in  
skeletal muscle
We defined the architecture of cyto-actin in wild-type skeletal 
muscle by immunostaining transverse cryosections of tibialis 
anterior (TA) and soleus muscles from 1-mo-old mice for cyto-
actin and its binding partner 2-spectrin (Fig. 1 A). Capillaries 
dominated the cyto-actin staining at the fiber bundle level and 
provided an internal positive control for cyto-actin immuno-
reactivity,  as  expected  from  the  abundance  of  cyto-actin  in 
endothelial cells (Galustian et al., 1995). However, a punctate 
cyto-actin staining pattern was still evident within the muscle 
fibers. Upon higher magnification examination of single fibers, 
cyto-actin exhibited partial colocalization with 2-spectrin at 
the sarcolemma, as expected (Repasky et al., 1982; Craig and 
Pardo, 1983; Nelson and Lazarides, 1983). Importantly, cyto-
actin did not colocalize at all with the myofibrils, which were 
identified by phalloidin staining for F-actin, confirming that 
the antibodies to cyto-actin did not cross react with sk-actin   
in myofibrils. We observed instead that cyto-actin and 2-spectrin 
localized to the intermyofibrillar compartments, which contain 
vesicular and membrane systems, mitochondria, and cyto-
plasmic components in skeletal muscle, consistent with previ-
ous observations that spectrin forms a reticular network between 
myofibrils (Repasky et al., 1982; Craig and Pardo, 1983). Iden-
tical cyto-actin staining patterns were observed using both rab-
bit pAb 7577 (Fig. 1 A; Hanft et al., 2006) and mouse mAb 
A8481 (Fig. 1, B and C), whose specificities were established 
using Western blotting on cell and tissue lysates with known 
actin isoform inventories (Fig. S1). Phalloidin stained myo-
fibrillar sk-actin but not the compartments containing cyto-actin 
(Fig. 1), even though phalloidin binds F-actin regardless of its 
actin isoform composition (Allen et al., 1996). We attribute this 
to the 4,500-fold greater abundance of sk-actin in myofibrils 
compared with cyto-actin in skeletal muscle (Hanft et al., 2006), 
which thus predominates over the cyto-actin signal.
Both Tmod1 and Tmod3 have been shown to associate with 
extrasarcomeric structures (Almenar-Queralt et al., 1999; Gokhin 
et al., 2010). To determine the localizations of these Tmods with 
respect to extrasarcomeric cyto-actin, we immunostained transverse 
sections of TA and soleus muscle for cyto-actin and either Tmod1 
or Tmod3. Both Tmod1 and Tmod3 colocalized with cyto-actin   
in extrasarcomeric compartments in wild-type muscle (Fig. 1, B 
and C), indicating that a combination of at least Tmod1 and 
Tmod3 can cap cyto-actin filament pointed ends in normal skeletal 
muscle. Capillaries exhibited the most pronounced Tmod3 fluores-
cence and provided an internal positive control for Tmod3 immuno-
reactivity, as Tmod3 is the unique Tmod isoform in the endothelial 
cells that comprise the microvasculature (Fischer et al., 2003).
Tmod2  is  predominantly  in  neuronal  tissues,  Tmod3  is 
ubiquitous, and Tmod4 is restricted to skeletal muscle fibers 
(Fowler, 1987, 1990; Sung et al., 1992; Watakabe et al., 1996; 
Almenar-Queralt et al., 1999; Cox and Zoghbi, 2000; Conley   
et al., 2001). Of these isoforms, only Tmod1 and Tmod4 nor-
mally localize to thin filament pointed ends in skeletal muscle 
(Fowler et al., 1993; Almenar-Queralt et al., 1999; Gokhin et al., 
2010). However, Tmod1 also colocalizes with 2-spectrin at the 
sarcolemma of fast muscle fibers in the chicken (Almenar-
Queralt et al., 1999) and can be detected at the A band/I band 
junction in isolated rat skeletal myofibrils (Fowler et al., 1993). 
Furthermore, Tmod3 localizes to the M line and regions flank-
ing the Z line in mouse muscles (Gokhin et al., 2010), which 
recapitulates the localizations of nonmuscle Tm4 and Tm5NM1 
in  the  SR  and  intracellular  membranes  (Kee  et  al.,  2004;   
Vlahovich et al., 2008, 2009). Therefore, based on their local-
izations at structures other than thin filament pointed ends, Tmods 
are likely candidates for capping extrasarcomeric cyto-actin and 
determining cyto-actin architecture in skeletal muscle. Because 
Tmod1 is known to regulate the architecture of nonmuscle F-actin 
in the spectrin-based membrane skeletons of nonmuscle cells 
(Nowak et al., 2009; Moyer et al., 2010), we hypothesized that 
perturbation of Tmod1 expression might alter extrasarcomeric 
cyto-actin architecture and provide clues about the function of 
cyto-actin in skeletal muscle.
To address our hypothesis, we used a genetic targeting 
approach to delete Tmod1 from skeletal muscle. Tmod1-null mice 
are embryonic lethal at embryonic day (E) 9.5 (Chu et al., 2003; 
Fritz-Six et al., 2003), but we were able to rescue their lethality 
with a cardiac-specific transgene that places Tmod1 under 
the control of the –myosin heavy chain (-MHC) promoter 
(Tmod1
/Tg(-MHC–Tmod1), hereafter referred to as Tmod1
/Tg+; 
McKeown et al., 2008). This enabled us to study the role of 
Tmod1 in skeletal muscle fibers, which start to develop at about 
E13 in the mouse (Miller, 1991). Tmod1
/Tg+ muscle generates 
less isometric stress than Tmod1
+/+Tg+ muscle, but this cannot 
be explained by changes in thin filament length in the absence 
of Tmod1, as compensatory substitution by Tmod3 and Tmod4 
at thin filament pointed ends functions to maintain correct thin 
filament lengths (Gokhin et al., 2010). This led us to specu-
late that the weakness of Tmod1
/Tg+ skeletal muscle may 
be a result of additional deficits arising from abnormalities in 
the extrasarcomeric actin cytoskeleton. In this study, we show 
that Tmod3 and cyto-actin establish an SR microdomain that 
is distinct from a second microdomain containing Tmod1 and 
Tmod4. The cyto-actin/Tmod3 microdomain is associated with 
an M line complex also containing small ankyrin 1.5 (sAnk1.5) 
and nonmuscle Tm4 and Tm5NM1. Deletion of Tmod1 causes 
Tmod3 to vacate its M line SR compartment and translocate 
to the thin filament pointed ends, leading to altered local-
ization of sAnk1.5, cyto-actin, Tm4, and Tm5NM1, abnormal 
SR morphologies, defects in Ca
2+ handling, and an increase in 
sarcomere misalignment that is more pronounced in more heav-
ily recruited muscles. Deletion of Tmod1 does not affect the 
organization of the 2-spectrin–ankyrin-B membrane skeleton, 
the desmin intermediate filament system, or the dystrophin– 
glycoprotein complex (DGC). We propose that Tmod3 mediates 107 Tropomodulins in the sarcoplasmic reticulum • Gokhin and Fowler
cyto-actin partially colocalized with the narrow Z line–flanking 
Tmod1 doublets in Tmod1
+/+Tg+ muscle and the Z line–flanking 
Tmod4 doublets in both Tmod1
+/+Tg+ and Tmod1
/Tg+ muscle 
(Figs. 2 A and S2). Examination of highly stretched myofibrils 
did not reveal any M line–associated Tmod1 or Tmod4 that 
might have been obscured by the bright Tmod1 or Tmod4 fluores-
cence at thin filament pointed ends (unpublished data). Thus, 
Tmod3 and cyto-actin define an extrasarcomeric compartment 
whose signature is an M line stripe and a wide Z line stripe, 
whereas Tmod1 and Tmod4 are predominantly associated with 
thin filament pointed ends, with a minor component localized 
to a second extrasarcomeric compartment whose signature is a 
doublet of narrow Z line–flanking stripes.
Although cyto-actin localized to the M line and across the 
Z line in both Tmod1
+/+Tg+ and Tmod1
/Tg+ muscle, we no-
ticed a modest attenuation of M line cyto-actin fluorescence in 
Tmod1
/Tg+ muscle (Fig. 2, A–C). To quantify this change,   
Deletion of Tmod1 perturbs the 
extrasarcomeric cyto-actin cytoskeleton
To investigate a potential role for Tmod1 in organizing cyto- 
actin with respect to myofibril/sarcomere striations, we immuno-
stained longitudinal sections of Tmod1
/Tg+ and Tmod1
+/+Tg+ 
TA muscle for cyto-actin and Tmods. In Tmod1
+/+Tg+ muscle, 
Tmod1  and  Tmod4  exhibited  their  well-established  local-
ization at the pointed ends of phalloidin-stained thin filaments, 
but these Tmods also localized to fainter stripes flanking the 
Z line (Figs. 2 A and S2). Tmod1 fluorescence was not detect-
able in Tmod1
/Tg+ muscle (Fig. 2 A), as expected (Gokhin   
et al., 2010). Tmod3 localized to the M line and to a wide stripe 
overlying the Z line in Tmod1
+/+Tg+ muscle, redistributing to 
thin filament pointed ends in Tmod1
/Tg+ muscle (Fig. 2 B), 
as shown previously (Gokhin et al., 2010). Notably, cyto-actin 
colocalized with Tmod3 at the M line and in a wide Z line–
flanking stripe in Tmod1
+/+Tg+ muscle (Fig. 2 B). Furthermore, 
Figure 1.  Tmods, cyto-actin, and spectrin localize to intermyofibrillar compartments in skeletal muscle. (A–C) Transverse cryosections of 1-mo-old TA 
muscle fiber bundles and single fibers immunostained for cyto-actin, 2-spectrin, and F-actin (A) or cyto-actin, F-actin, and either Tmod1 (B) or Tmod3 (C). 
Arrowheads indicate intermyofibrillar compartments enriched for Tmods, cyto-actin, and 2-spectrin. Asterisks indicate capillaries. Bars, 25 µm.JCB • VOLUME 194 • NUMBER 1 • 2011   108
statistically significant decrease in Tmod4 Z/P fluorescence was 
observed in Tmod1
/Tg+ muscle (Fig. 2 E). This suggests that a 
small amount of Tmod4 is lost from the Z line–flanking doublets, 
redistributing to the thin filament pointed ends in the absence of 
Tmod1. These observations strengthen the notion that both Tmod3 
and Tmod4 structurally compensate for the absence of Tmod1 by 
capping thin filament pointed ends (Gokhin et al., 2010).
To determine whether cyto-actin and Tmod3 at the M line 
and spanning across the Z line were associated with a spec-
trin cytoskeleton, we immunostained longitudinal sections of 
TA muscle for cyto-actin and 2-spectrin. Both cyto-actin and   
2-spectrin localized in a narrow band at the M line and in a broad 
band across the Z line in both Tmod1
+/+Tg+ and Tmod1
/Tg+  
muscle  (Fig.  2  C).  In  contrast  to  cyto-actin,  the  ratio  of   
2-spectrin M/Z fluorescence was unchanged in Tmod1
/Tg+ 
muscle (Fig. 2 D). Western blotting also showed no changes 
in 2-spectrin levels in Tmod1
/Tg+ muscle (Fig. S3). Thus,   
2-spectrin shares an extrasarcomeric compartment with cyto-
actin and Tmod3, but cyto-actin alterations and Tmod3 trans-
location  downstream  of  Tmod1  deletion  do  not  perturb  the 
extrasarcomeric spectrin network.
we integrated cyto-actin fluorescence intensity along line scans 
of myofibrils and measured the ratio of M line to Z line (M/Z)   
fluorescence. We found that the ratio of M/Z fluorescence 
decreased from 0.20 in Tmod1
+/+Tg+ muscle to 0.15 in   
Tmod1
/Tg+ muscle, a decrease of 25% (Fig. 2 D), which 
suggests that the deletion of Tmod1 and concomitant transloca-
tion of Tmod3 alter the architecture of extrasarcomeric cyto-
actin in skeletal muscle. However, the total levels of cyto-actin 
were unchanged in Tmod1
/Tg+ muscle (Fig. S3), similar to 
Tmod3 (Gokhin et al., 2010). Interestingly, the ratio of Tmod3 
M/Z  fluorescence  in  Tmod1
+/+Tg+  muscle  was  also  0.20 
(Fig. 2 D), indicating that cyto-actin and Tmod3 are partitioned 
with a similar pattern across extrasarcomeric striated compart-
ments. Thus, cyto-actin is associated with Tmod3 in an extra-
sarcomeric cytoskeletal compartment overlaying the M line and 
in a broad band flanking the Z line.
A similar quantitative image analysis was performed for the 
ratio of Z line to pointed end (Z/P) fluorescence for Tmod1 in 
Tmod1
+/+Tg+ muscle, Tmod3 in Tmod1
/Tg+ muscle, and Tmod4 
in both Tmod1
+/+Tg+ and Tmod1
/Tg+ muscle. The ratio of Z/P 
fluorescence was 0.37 for all Tmods, although a modest but   
Figure 2.  Tmods and cyto-actin exhibit two distinct extrasarcomeric localizations at the M line and flanking the Z line, and deletion of Tmod1 depletes 
cyto-actin from the M line. (A–C) Longitudinal cryosections of 1-mo-old TA muscle fibers from Tmod1
+/+Tg+ and Tmod1
/Tg+ mice immunostained for cyto-
actin, F-actin, and either Tmod1 (A), Tmod3 (B), or 2-spectrin (C). (D and E) Quantitation of the ratio of M/Z (D) and Z/P (E) fluorescence of cyto-actin, 
2-spectrin, and Tmods. Each bar reflects n = 91–99 myofibrils/genotype measured from three mice (six muscles)/genotype for cyto-actin, 2-spectrin, 
and Tmod3 or n = 42–83 myofibrils/genotype measured from two mice (four muscles)/genotype for Tmod1 and Tmod4. *, P < 0.001. M, M line; P, thin 
filament pointed ends; Z, Z line. Data are presented as mean ± SD. Bars, 1 µm.109 Tropomodulins in the sarcoplasmic reticulum • Gokhin and Fowler
thin filament pointed ends in the absence of Tmod1 (Fig. 2 E).   
These results confirm that Tmod3 and Tmod4 rearrange and 
establish a structural compensatory mechanism in the absence of 
Tmod1. However, the amounts of Tmod3 and cyto-actin in the 
15,000- and 150,000-g pellets did not change in Tmod1
/Tg+ 
muscle. This may be because whole-muscle homogenates and 
their fractions are contaminated with erythrocytes (a nonmuscle 
source of Tmod1) and endothelial cells (a nonmuscle source 
of Tmod3 and cyto-actin; Fowler, 1987, 1990; Galustian et al., 
1995; Conley et al., 2001; Fischer et al., 2003). This may have 
skewed the distributions of Tmod1, Tmod3, and cyto-actin in 
favor of the higher-speed pellets and obscured small changes in 
the fractionation patterns.
Deletion of Tmod1 alters the localization of 
sAnk1.5, a novel binding partner of Tmod3
To investigate whether the changes downstream of Tmod1 dele-
tion (i.e., Tmod3 translocation to the thin filament pointed ends 
and perturbation of cyto-actin) might cause global changes in 
SR cytoskeletal organization, we screened localizations of 
SR-associated cytoskeletal proteins. Interestingly, the only pro-
tein that we found to be systemically mislocalized in Tmod1
/Tg+ 
Tmods and cyto-actin define two distinct 
SR microdomains
The SR membrane system wraps around myofibrils and serves 
as the Ca
2+ reservoir for muscle contraction. The SR membranes 
flank the Z line, where the terminal cisternae of the longitudinal 
SR are coupled to the transverse tubules at the triads, and are 
also located at the M line, where the fenestrated collar forms a 
sheath around the center of the sarcomere. Immunostaining of 
longitudinal sections of Tmod1
+/+Tg+ and Tmod1
/Tg+ muscle 
revealed that two key SR-associated Ca
2+ channels in skeletal 
muscle, RyR1 and sarco/ER Ca
2+ ATPase 1 (SERCA1), local-
ize in a striated pattern at the M line and flanking the Z line.   
In both Tmod1
+/+Tg+ and Tmod1
/Tg+ muscle, RyR1 staining 
was predominantly enriched at the M line with fainter Z line– 
flanking stripes in a pattern distinct from either Tmods or cyto-
actin (Fig. 3 A), whereas SERCA1 staining was present in a 
broad band around the Z line with a fainter M line stripe, resem-
bling the staining patterns of cyto-actin, Tmod3, and 2-spectrin   
(Fig. 3 B). For both RyR1 and SERCA1, total protein levels and 
the ratio of M/Z fluorescence were identical in Tmod1
+/+Tg+ and 
Tmod1
/Tg+ muscle (unpublished data). These data suggest 
that extrasarcomeric cyto-actin, Tmod3, and 2-spectrin are   
associated with an SR compartment also containing SERCA1, 
whereas Tmod1 and Tmod4 may be associated with a sub-
domain of the RyR1-containing SR compartment flanking the   
Z line. However, Tmod1 deletion affects neither the levels nor the 
localization of these two major SR-associated Ca
2+ channels.
To discern in more detail how actins and Tmods sort   
across skeletal muscle compartments, we subjected Tmod1
+/+Tg+ 
and Tmod1
/Tg+ TA muscle homogenates to differential cen-
trifugation and Western blotting for sk-actin, RyR1, SERCA1, 
cyto-actin, Tmod1, Tmod3, and Tmod4 (Fig. 4). As expected 
from previous differential centrifugation experiments (Knight 
and Trinick, 1982; Fowler et al., 1993), 90% of sk-actin was 
contained in the 1,500-g pellet (which mainly contains myo-
fibrils), and the remaining 10% was in the cytosol. Both RyR1 
and SERCA were predominantly in the 15,000-g pellet (which 
mainly contains membranes and organelles) and the 150,000-g 
pellet (which mainly contains microsomes and macromolecular 
complexes) of muscles of both genotypes. Although cyto-actin 
and Tmod3 were present in all fractions, they were enriched in 
the 15,000- and 150,000-g pellets, tending to cofractionate with 
the SR markers. Tmod1 and Tmod4 fractionated predominantly 
in the 1,500-g pellet along with the myofibrils, with smaller 
fractions in the 15,000-g pellet and cytosol. Thus, Tmod1 and 
Tmod4 have a biochemical fractionation signature distinct 
from cyto-actin and Tmod3, consistent with the distinct immuno-
fluorescence staining signatures of Tmod1/Tmod4 versus cyto-
actin/Tmod3 (Fig. 2). The fraction of Tmod3 in the 1,500-g 
myofibrillar pellet increased from 17% in Tmod1
+/+Tg+ mus-
cle to 33% in Tmod1
/Tg+ muscle and was accompanied by 
a corresponding depletion of Tmod3 from the cytosol fraction, 
consistent with Tmod3 translocation to thin filament pointed 
ends in the absence of Tmod1 (Fig. 2 B; Gokhin et al., 2010). 
The fraction of Tmod4 in the 1,500-g pellet increased from 
46% in Tmod1
+/+Tg+ muscle to 53% in Tmod1
/Tg+ muscle, 
again consistent with a small amount of Tmod4 translocation to 
Figure 3.  Extrasarcomeric structures containing cyto-actin and Tmods co-
localize with the SR. (A and B) Longitudinal cryosections of 1-mo-old TA 
muscle fibers from Tmod1
+/+Tg+ and Tmod1
/Tg+ mice immunostained for 
RyR1, cyto-actin, and F-actin (A) and SERCA1, Tmod4, and F-actin (B).   
M, M line; P, thin filament pointed ends; Z, Z line. Bars, 1 µm.JCB • VOLUME 194 • NUMBER 1 • 2011   110
muscle (Figs. 5 C and S3). In contrast, obscurin (an sAnk1.5 
binding partner) and ankyrin-B (a large canonical ankyrin iso-
form) had unchanged localizations in Tmod1
/Tg+ muscle, with 
the narrow M line and wide Z line staining patterns character-
istic of the cyto-actin/Tmod3 SR microdomain (Fig. S4) and 
identical to 2-spectrin (Fig. 2 C).
To understand the molecular mechanism for sAnk1.5 mis-
localization in Tmod1
/Tg+ muscle, we performed coimmuno-
precipitation (co-IP) experiments using muscle extracts. Tmod3 
and cyto-actin coimmunoprecipitated with anti-sAnk1.5–coated 
beads, and, in an inverse experiment, sAnk1.5 and cyto-actin co-
immunoprecipitated with anti-Tmod3–coated beads (Fig. 5 D).   
Tmod1 and sAnk1.5 did not coimmunoprecipitate with anti-
sAnk1.5– and anti-Tmod1–coated beads, respectively (Fig. 5 D),   
muscle was sAnk1.5, a 17-kD splice variant of ankyrin-R that 
links the SR to the M line by binding to obscurin (Bagnato et al., 
2003; Kontrogianni-Konstantopoulos et al., 2003; Porter et al.,   
2005; Lange et al., 2009). In Tmod1
+/+Tg+ muscle, sAnk1.5   
localizes predominantly to the M line as reported (Bagnato et al., 
2003; Kontrogianni-Konstantopoulos et al., 2003; Lange et al., 
2009), although low levels of Z line–associated sAnk1.5 could 
also be detected (Fig. 5 A). However, in Tmod1
/Tg+ muscle, 
sAnk1.5  immunostaining  revealed  a  wide  stripe  overlaying 
the Z line that resembled the staining pattern of the cyto-actin/
Tmod3 SR microdomain (Fig. 5 A). This change in localization 
was confirmed quantitatively by an 95% reduction in the ratio 
of sAnk1.5 M/Z fluorescence in Tmod1
/Tg+ muscle (Fig. 5 B). 
However, sAnk1.5 protein levels did not change in Tmod1
/Tg+ 
Figure 4.  Differential centrifugation of skeletal muscle proteins reveals that Tmods and cyto-actin cofractionate with SR membranes. (A) Western blots of 
TA tissue homogenate, 1,500-g pellet, 15,000-g pellet, 150,000-g pellet, and cytosol from Tmod1
+/+Tg+ and Tmod1
/Tg+ mice. Loading of fractions was 
normalized with respect to the initial volume of the total homogenate. Blots were probed for sk-actin, RyR1, SERCA1, cyto-actin, Tmod1, Tmod3, Tmod4, 
Tm4, and Tm5NM1. (B) Quantitation of Western blots. Each bar reflects the mean of three independent blots. The proportions of Tmod3 in the 1,500-g 
and cytosolic fractions and the proportion of Tmod4 in the 1,500-g fraction were significantly different between Tmod1
+/+Tg+ and Tmod1
/Tg+ muscle   
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Figure 5.  Tmod3 and cyto-actin form a complex with sAnk1.5, which appears at the Z line in the absence of Tmod1. (A) Longitudinal cryosections of 
1-mo-old TA muscle fibers from Tmod1
+/+Tg+ and Tmod1
/Tg+ mice immunostained for cyto-actin, F-actin, and sAnk1.5. M, M line; Z, Z line. Bars, 1 µm. 
(B) Quantitation of the ratio of M/Z fluorescence of sAnk1.5. Each bar reflects n = 59–63 myofibrils/genotype measured from three mice (six muscles)/
genotype. Data are presented as mean ± SD. ***, P < 0.001. (C) Western blots of EDL tissue lysates show no changes in sAnk1.5 levels in Tmod1
/Tg+ 
mice. (D) Western blots of clarified muscle extract (input) coimmunoprecipitated using antibodies against sAnk1.5, Tmod1, or Tmod3 or their respective 
negative controls. Note the co-IP of Tmod3, cyto-actin, nonmuscle Tms, and sAnk1.5 but not Tmod1, 2-spectrin, ankyrin-B, RyR1, or SERCA1. (E) Western 
blots of clarified muscle extract coimmunoprecipitated using antibodies against sAnk1.5 or Tmod3 show reduced co-IP of sAnk1.5, Tmod3, and cyto-actin 
in Tmod1
/Tg+ muscle. (F) Quantitation of sAnk1.5, Tmod3, and cyto-actin protein ratios in coimmunoprecipitated Tmod1
+/+Tg+ and Tmod1
/Tg+ muscle 
extract. Each bar reflects n = 3 lanes. Data are presented as mean ± SD. *, P < 0.05; **, P < 0.01. (G) Coomassie-stained gel of purified proteins used 
for GST pull-down experiments. (H) Western blots of bound and unbound fractions of Tmod1 or Tmod3 pulled down by glutathione resin alone or resin 
loaded with GST or GST-sAnk1.5.JCB • VOLUME 194 • NUMBER 1 • 2011   112
that Tmod3 (but not Tmod1) binds directly to sAnk1.5 (Fig. 5,   
G and H). The sAnk1.5–Tmod3 interaction may be weak in vitro, 
as most of the Tmod3 incubated with GST-sAnk1.5 remained 
in the unbound fraction (Fig. 5 H). Regardless, direct binding 
of Tmod3 to GST-sAnk1.5 and co-IP of Tmod3 and cyto-actin 
from muscle extracts with sAnk1.5 antibodies demonstrate that 
Tmod3 and cyto-actin can establish direct cytoskeletal linkages 
to the SR via a specific SR constituent, sAnk1.5.
The SR is structurally and functionally 
compromised in the absence of Tmod1
To  investigate  whether  the  absence  of Tmod1,  translocation 
of Tmod3, disruption of cyto-actin, and mislocalization of 
sAnk1.5 might be accompanied by morphological changes in 
the SR, we performed transmission EM (TEM) on Tmod1
+/+Tg+ 
and Tmod1
/Tg+ muscle. This revealed pathological swelling 
of the SR in Tmod1
/Tg+ muscle that was comparatively rare 
in Tmod1
+/+Tg+ muscle (Fig. 6, A and B). Closer examination of 
these defects revealed swollen, electron-lucent SR vesicles be-
tween myofibrils, particularly in the vicinity of Z lines (Fig. 6,   
C and D). Z lines and triads tended to be displaced from the 
regions containing swollen SR, although triad morphology ap-
peared normal (Fig. 6, A–D). Occasional instances of mito-
chondrial swelling were also observed but were not significantly 
more abundant (0.90 ± 0.85 vs. 1.20 ± 1.15 mitochondrial 
defects/5,800× field in Tmod1
+/+Tg+ vs. Tmod1
/Tg+ muscle, 
respectively; P = 0.36). SR defects were approximately three-
fold more prevalent in Tmod1
/Tg+ muscle than in Tmod1
+/+Tg+ 
muscle (Fig. 6 E), although the frequency of SR defects in 
Tmod1
/Tg+ muscle was quite variable (coefficient of varia-
tion = 0.68). SR defects were focal, and the majority of the 
SR was intact in Tmod1
/Tg+ muscle, which may explain why 
RyR1 and SERCA1 immunofluorescence appeared normal in 
Tmod1
/Tg+ muscle (Fig. 3) despite the large number of SR   
defects evident by TEM. To determine whether these defects   
adversely impact SR Ca
2+ handling, we used a fluorescence-
based Ca
2+ flux assay to compare SR Ca
2+ release in suspensions 
of TA muscle fibers immediately after cholinergic stimulation 
by  exogenous  acetylcholine  (ACh).  Peak ACh-induced  Ca
2+ 
flux in Tmod1
/Tg+ muscle fibers was reduced by 15% com-
pared with Tmod1
+/+Tg+ fibers (Fig. 6 F), indicating defective 
Ca
2+ release, which is consistent with SR defects in the absence 
of Tmod1. Therefore, the absence of Tmod1, translocation of 
Tmod3, and disruption of cyto-actin produce defects in both the 
structure and function of the SR.
Deletion of Tmod1 perturbs nonmuscle 
Tms in skeletal muscle
Nonmuscle Tm4 and Tm5NM1 play important physiological 
roles in regulating SR morphology and excitation–contraction 
coupling in skeletal muscle (Kee et al., 2004; Vlahovich et al., 
2008, 2009). The abnormal SR morphology and the loss of 
cyto-actin from the M line in the absence of Tmod1 led us to ask 
whether nonmuscle Tm4 and Tm5NM1 are perturbed in the 
absence of Tmod1. Immunostaining of longitudinal sections 
of Tmod1
+/+Tg+ and Tmod1
/Tg+ muscle revealed that both Tm4 
and Tm5NM1 localize to stripes at the M line and flanking the 
indicating that Tmod participation in this complex is Tmod3 
specific. Moreover, neither 2-spectrin, ankyrin-B, RyR1, nor 
SERCA1 coimmunoprecipitated with either sAnk1.5 or Tmod3 
(Fig. 5 D). Thus, sAnk1.5, Tmod3, and cyto-actin establish a novel 
SR-associated protein complex at the M line. Comparison of 
co-IPs from Tmod1
/Tg+ and Tmod1
+/+Tg+ muscles showed that 
less Tmod3 and cyto-actin were associated with anti-sAnk1.5–
coated beads and, similarly, that less sAnk1.5 and cyto-actin were 
associated with anti-Tmod3–coated beads (Figs. 5 [E and F]  
and S5). Thus, the Tmod3–cyto-actin–sAnk1.5 complex par-
tially dissociates when Tmod3 leaves the SR and translocates 
to the thin filament pointed ends in the absence of Tmod1. 
Furthermore, GST-sAnk1.5 pull-down experiments revealed 
Figure 6.  Deletion of Tmod1 produces ultrastructural defects in the SR 
and depresses SR Ca
2+ release. (A and B) TEM of 6-mo-old longitudinal EDL 
muscle sections from Tmod1
+/+Tg+ (A) and Tmod1
/Tg+ (B) mice. Bars, 1 µm. 
(C  and  D)  Higher-magnification  TEM  of  the  SR  of  Tmod1
+/+Tg+  (C) 
and Tmod1
/Tg+ (D) muscle. M, mitochondria; T, triads. Bars, 0.5 µm.   
(E) Quantitation of SR defects in Tmod1
+/+Tg+ and Tmod1
/Tg+ EDL muscle 
at 5,800× magnification. Each bar reflects n = 20 images/genotype from 
two mice (four muscles)/genotype. (F) Ca
2+ flux as a function of ACh con-
centration for Tmod1
+/+Tg+ and Tmod1
/Tg+ TA fiber suspensions. Note 
the reduced Ca
2+ flux in Tmod1
/Tg+ fibers. Each data point reflects the 
mean of four independent experiments. Data are presented as mean ± SD.   
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Tmod3, and cyto-actin but not with Tmod1 (Fig. 5 D). Thus, 
nonmuscle Tms are associated with the cyto-actin/Tmod3 SR 
microdomain in skeletal muscle, including the M line Tmod3–
sAnk1.5 complex, where they presumably stabilize cyto-actin 
filaments  by  binding  along  their  sides  and  interacting  with 
Tmods at cyto-actin pointed ends.
Deletion of Tmod1 increases sarcomere 
misalignment but does not perturb desmin 
or the DGC
Intact cytoskeletal connections among core myofibrils, periph-
eral myofibrils, and sarcolemma are important for maintaining 
sarcomere alignment and providing efficient lateral force trans-
mission during muscle contraction (Monti et al., 1999; Shah   
et al., 2004; Meyer et al., 2010). Because cyto-actin perturba-
tion, Tmod3 translocation, and sAnk1.5 mislocalization in the 
absence of Tmod1 produce defects in the SR in the vicinity of 
the Z line, we used TEM of 1- and 6-mo-old muscles to exam-
ine whether Tmod1
/Tg+ muscles exhibit elevated sarcomere 
misalignment. TEM revealed a small and age-dependent increase 
in sarcomere misalignment in Tmod1
/Tg+ extensor digitorum 
longus (EDL) muscle, as determined by normalizing longitudinal 
Z line, similar to cyto-actin (Fig. 7, A and B). Western blotting 
did not show any changes in the levels of Tm4 and Tm5NM1 in 
Tmod1
/Tg+ muscle (Figs. 7 [C and D] and S3). However, for 
both Tm4 and Tm5NM1, the ratio of M/Z fluorescence was 
0.23 in Tmod1
+/+Tg+ muscle, decreasing by 25% to 0.18 in 
Tmod1
/Tg+ muscle (Fig. 7 E), which was strikingly similar to 
the redistribution of cyto-actin (Fig. 2 D). Therefore, the dele-
tion of Tmod1 results in redistribution of nonmuscle Tms from 
the M line to the Z line, paralleling cyto-actin. Both Tm4 and 
Tm5NM1 cofractionated with cyto-actin and Tmod3 in the 
15,000- and 150,000-g pellets, similar to SR markers, and a 
larger proportion of Tm4 than Tm5NM1 was associated with 
the 15,000-g pellet (41 vs. 29%, respectively), which was 
unchanged in Tmod1
/Tg+ muscle (Fig. 4). Most likely, the per-
turbation of nonmuscle Tms revealed by immunofluorescence 
may have been insufficient to change the relative proportions 
of the nonmuscle Tms in the SR-associated fractions. Alterna-
tively, contamination of the muscle homogenates by nonmuscle 
cells may have suppressed our ability to detect changes in the 
sorting of Tm isoforms across muscle compartments in the ab-
sence of Tmod1, similar to the case of cyto-actin. Furthermore, 
both Tm4 and Tm5NM1 coimmunoprecipitated with sAnk1.5, 
Figure 7.  Deletion of Tmod1 depletes nonmuscle Tms from the M line. (A and B) Longitudinal cryosections of 1-mo-old TA muscle fibers from Tmod1
+/+Tg+ 
and Tmod1
/Tg+ mice immunostained for cyto-actin, F-actin, and either Tm4 (A) or Tm5NM1 (B). M, M line; Z, Z line. Bars, 1 µm. (C and D) Western blots 
of EDL tissue lysates show no changes in Tm4 (C) and Tm5NM1 (D) levels in Tmod1
/Tg+ muscle. (E) Quantitation of M/Z fluorescence of Tms. Each bar 
reflects n = 52–61 myofibrils/genotype measured from three mice (six muscles)/genotype. Data are presented as mean ± SD. *, P < 0.001.JCB • VOLUME 194 • NUMBER 1 • 2011   114
dependent than in the EDL (Fig. 8, A, B, E, and F). Because the 
soleus is a slower and more heavily recruited muscle than the 
EDL, the magnitude of sarcomere misalignment in the absence 
of Tmod1 is muscle type dependent. Thus, the fortification of 
the SR by cyto-actin, Tmod3, sAnk1.5, and nonmuscle Tms 
plays a novel role in maintaining the alignment of adjacent 
myofibrils during muscle contraction and use.
Elevated sarcomere misalignment in Tmod1
/Tg+ muscle 
led us to ask whether the organization of the desmin inter-
mediate filament network, which is known to mechanically align 
myofibrils (Milner et al., 1996; Shah et al., 2002, 2004; Meyer 
et al., 2010), might be altered in the absence of Tmod1. Desmin 
levels were unchanged in Tmod1
/Tg+ muscle (Figs. 9 A and 
S3), and no obvious changes in desmin localization were identi-
fied in Tmod1
/Tg+ muscle, with desmin localizing to Z lines 
and more faintly to M lines in both genotypes (Fig. 9 D). Des-
min transmits contractile force to the sarcolemma by interacting 
with its binding partners at the costamere, which is composed of 
the DGC and other subcomplexes. The DGC is anchored by the 
giant protein dystrophin, an integral costamere constituent and 
cyto-actin–binding protein (Renley et al., 1998; Rybakova et al., 
2000). Therefore, we examined whether cyto-actin alterations 
in the absence of Tmod1 might perturb the DGC. We found no 
changes in -dystroglycan or dystrophin levels (Figs. 9 [B and C]   
and S3) or localization (Fig. 9 E) in Tmod1
/Tg+ muscle. This, 
and the fact that skeletal muscle–specific deletion of cyto-actin 
has no effect on the DGC (Sonnemann et al., 2006), indicates 
that neither normal Tmod1 levels nor correct pointed end regu-
lation of extrasarcomeric cyto-actin by Tmod1 is required for 
assembly and targeting of the DGC to the sarcolemma.
Discussion
Tmods and cyto-actin stabilize the SR
We have identified two distinct SR-associated compartments 
that contain cyto-actin and its binding partners. The first has a 
narrow M line and wide Z line–flanking signature and contains 
Tmod3, cyto-actin, nonmuscle Tms, 2-spectrin, ankyrin-B, and 
obscurin, whereas the second has a narrow Z line–flanking doublet 
signature and contains Tmod1 and Tmod4. The first cyto-actin 
compartment has a similar staining pattern as SERCA1, whereas 
the second cyto-actin compartment resembles the narrow RyR1 
doublets flanking the Z line but not at the M line. We propose 
that, in Tmod1
+/+Tg+ muscle, extrasarcomeric cyto-actin pointed 
ends are predominantly capped by Tmod3, with smaller contri-
butions from Tmod1 and Tmod4 (this study), whereas Tmod1 
and Tmod4 cap thin filament pointed ends (Gokhin et al., 2010). 
Tmod3 may regulate SR-associated cyto-actin by inhibiting the 
dissociation  of  actin  monomers  from  pointed  ends,  stabiliz-
ing filaments and linking cyto-actin filament pointed ends to 
the SR membrane via Tmod3 binding to sAnk1.5 (Fig. 10).   
SR-associated cyto-actin filaments may be further stabilized by 
the binding of nonmuscle Tm4 and Tm5NM1, similar to Tmods 
in other actin filament systems (Weber et al., 2007; Nowak et al., 
2009; Moyer et al., 2010). In Tmod1
/Tg+ muscle, Tmod1 is 
absent from the SR, and Tmod3 redistributes from the SR to 
the thin filament pointed ends in sarcomeres, thus destabilizing   
Z line offset to sarcomere length (z/Ls; Fig. 8, A–D). Sarcomere 
misalignment  was  more  pronounced  in  Tmod1
/Tg+  soleus 
muscle, with 15% of myofibrils exhibiting z/Ls > 0.25,   
although  myofibril  misalignment  in  the  soleus  was  less  age   
Figure 8.  Deletion of Tmod1 produces an age-dependent increase in sar-
comere misalignment. (A and B) TEM of 1- (A) and 6-mo-old (B) longitudinal 
EDL muscle sections from Tmod1
+/+Tg+ and Tmod1
/Tg+ mice. Bars, 1 µm. 
(C–F) Frequency distribution of z/Ls in EDL (C and D) and soleus (E and F)   
muscles  from  1-  (C  and  E)  and  6-mo-old  (D  and  F)  Tmod1
+/+Tg+  and 
Tmod1
/Tg+ mice. Each distribution reflects n = 34–72 myofibrils/geno-
type for 1-mo-old mice and n = 239–881 myofibrils/genotype for 6-mo-old 
mice measured from two mice/age/genotype (four muscles/age/geno-
type), which were collected in a single experiment.115 Tropomodulins in the sarcoplasmic reticulum • Gokhin and Fowler
proteins, including SR-associated ion channels in striated muscle 
(Bennett and Healy, 2008; Cunha and Mohler, 2009). Our data 
implicate Tmods as a novel class of molecules that compart-
mentalize the skeletal muscle SR via linkages to sAnk1.5 at the 
M line. sAnk1.5 is a 17-kD skeletal muscle–specific splice vari-
ant of ankyrin-R (Ank1) that lacks the N-terminal tandem repeat 
and spectrin-binding domains of canonical ankyrins and, in their 
place, contains a unique 73–amino acid–long N-terminal domain 
with  a  22-residue  hydrophobic  membrane-binding  sequence 
(Gallagher  et  al.,  1997;  Gallagher  and  Forget,  1998;  Porter   
et  al.,  2005).  Our  co-IP  and  immunostaining  results  show 
that Tmod3, cyto-actin, and nonmuscle Tms form a complex 
with sAnk1.5 at the M line that is distinct from 2-spectrin or   
ankyrin-B complexes and that does not contain SERCA1 or RyR1. 
sAnk1.5 is targeted to the M line by binding to obscurin, a giant 
protein that is anchored to myomesin and titin in the thick fila-
ments (Fukuzawa et al., 2008). We propose that Tmod3 binding 
to obscurin-tethered sAnk1.5 recruits cyto-actin and nonmuscle 
Tms to an SR microdomain at the M line. In this event, Tmod3 
may interact with a site on sAnk1.5 distinct from its obscurin-
binding site (Borzok et al., 2007). However, because obscurin 
remains at the M line in the absence of Tmod1, yet sAnk1.5 
mislocalizes to the Z line when Tmod3 translocates to thin fila-
ment pointed ends, additional factors may anchor Tmod3 and 
sAnk1.5 to the M line SR compartment. Obscurin-null muscle 
also exhibits sAnk1.5 mislocalization to the Z line along with 
retraction of the longitudinal SR toward the Z line (Lange et al., 
2009), but SR retraction is not observed in Tmod1-null muscle 
(Figs. 6 and 8). Regardless, mislocalization of sAnk1.5 when 
Tmod3 vacates the M line in the absence of Tmod1 argues 
that the secondary rearrangement of Tmod3 in the absence of 
Tmod1 induces systemic SR alterations in Tmod1
/Tg+ muscle. 
the SR-associated cyto-actin complex of Tmod3, Tm4, and 
Tm5NM1 with sAnk1.5 (Fig. 10). The loss of cyto-actin–mediated 
connectivity in Tmod1
/Tg+ muscle may mechanically weaken   
the SR, producing aberrant SR swelling and depressed Ca
2+ re-
lease. The disruption of linkages between the SR and myofibrils 
could then cause myofibril misalignment that becomes more 
pronounced  as  muscles  are  recruited  more  frequently,  thereby 
imposing chronic mechanical stress on a structurally compromised 
cytoskeletal network.
Our findings provide a mechanism that can explain the 
physiological alterations in Tmod1
/Tg+ muscle. We have shown 
previously that absence of Tmod1 does not alter thin filament 
lengths because of structural compensation by Tmod3 and Tmod4 
(Gokhin et al., 2010). Even though thin filament lengths are nor-
mal in Tmod1
/Tg+ muscle, Tmod1
/Tg+ muscle still exhibits 
depressed isometric stress production (Gokhin et al., 2010). We 
propose that a combination of defects in Ca
2+ release and lateral 
force transmission underlies this functional deficit. Our Ca
2+ flux 
assays show that SR defects in the absence of Tmod1 lead to in-
adequate Ca
2+ release and incomplete thin filament activation. 
Furthermore, when cyto-actin and the SR are disrupted in the 
absence of Tmod1, adjacent myofibrils become mechanically de-
coupled, leading to myofibril misalignment and a likely depression 
in the net force transmitted to the cell exterior. Either mechanism 
can produce a muscle phenotype whereby depressed isometric 
stress production and locomotor behavior lead to fiber-type re-
programming that reflects decreased use (Gokhin et al., 2010).
Skeletal muscle fibers contain a nonmuscle-
like, SR-associated cytoskeleton
Membrane adaptors such as ankyrins link spectrin–actin net-
works and spectrin-based membrane skeletons to membrane 
Figure 9.  Intact desmin intermediate filament network and DGC in the absence of Tmod1. (A–C) Western blots of EDL tissue lysates show no changes in 
desmin (A), -dystroglycan (B), and dystrophin (C) levels in Tmod1
/Tg+ mice. (D) Longitudinal cryosections of 1-mo-old TA muscle fibers from Tmod1
+/+Tg+ 
and Tmod1
/Tg+ mice immunostained for desmin, Tmod4, and F-actin. M, M line; P, thin filament pointed ends; Z, Z line. Bars, 1 µm. (E) Transverse cryo-
sections of 1-mo-old TA muscle fibers from Tmod1
+/+Tg+ and Tmod1
/Tg+ mice immunostained for -dystroglycan and dystrophin. Bars, 25 µm.JCB • VOLUME 194 • NUMBER 1 • 2011   116
facilitate Tmod1 and Tmod4 binding to thin filament pointed 
ends. Alternatively, binding of Tmod3 to sAnk1.5 could specifi-
cally target Tmod3 and cyto-actin filaments to the SR. Either 
mechanism is consistent with the phenotype of Tmod1
/Tg+ 
muscle (Gokhin et al., 2010; this study), in which Tmod–actin 
isoform interactions in skeletal muscle appear to be biochemically 
tuned in a manner that prioritizes sk-actin thin filament length 
regulation over cyto-actin regulation. Such actin isoform–specific 
biochemistry  likely  arises  from  differential  molecular  inter-
actions of various combinations of actins, Tmods, and Tms.
Multiple cytoskeletal systems align 
adjacent myofibrils
Maintaining alignment among adjacent myofibrils is a function 
that has canonically been ascribed to desmin intermediate fila-
ments (Milner et al., 1996; Shah et al., 2002, 2004; Meyer et al., 
2010). Because the absence of Tmod1 and the translocation of 
Tmod3 lead to a reorganization of intermyofibrillar cyto-actin, 
sAnk1.5 mislocalization, SR defects, and increased sarcomere 
misalignment, the SR membrane itself, mechanically fortified 
by cyto-actin, is involved in aligning myofibrils. By tethering 
together adjacent myofibrils, the SR can reduce intermyofib-
rillar sliding during muscle deformation. Previous data have   
suggested that the C terminus of nebulin may act as a bridge 
between desmin and sk-actin at the Z line and that desmin 
binding to nebulin mediates both thin filament lengths and myo-
fibril alignment (Bang et al., 2002; Conover et al., 2009; Tonino 
et al., 2010). However, thus far, there is no evidence for a simi-
lar protein bridge between desmin and cyto-actin in the SR.   
Because the absence of Tmod1 does not perturb the desmin inter-
mediate filament system (this study) or the localizations of the 
N and C termini of nebulin (Gokhin et al., 2010), these cyto-
skeletal systems appear to be decoupled in terms of their bio-
chemistry while remaining homologous in terms of their function. 
It is appealing to speculate that redundant and functionally   
homologous protein systems evolved as a fail-safe mechanism 
to ensure correct striated muscle function.
Implications for the phenotypes of mice 
with altered cyto-actin levels
Based on its strategic enrichment at costameres, interaction with 
dystrophin,  and  dramatic  up-regulation  in  dystrophic  muscles,   
However, the normal localizations of RyR1 and SERCA1 and 
the focal SR defects in Tmod1
/Tg+ muscle argue that defects 
may simply occur in focal sites of elevated mechanical stress 
that arise during muscle contraction and use.
The role that Tmod3 plays in organizing extrasarcomeric 
cyto-actin in the SR is analogous to the roles that Tmods play in 
lens fiber cells and erythrocytes, in which deletion of Tmod1 
results in misregulation of membrane-associated F-actin, reduced 
Tm–F-actin association, and perturbation of the spectrin-based 
membrane skeleton, manifested physiologically as defects in 
cell morphology and mechanics (Nowak et al., 2009; Moyer   
et al., 2010). A similar result is observed in confluent cultures of 
polarized epithelial cells, in which short hairpin RNA–mediated 
knockdown of Tmod3 results in the loss of F-actin and Tm from 
lateral membranes, disruption of 2-spectrin, and reduction in 
cell height (Weber et al., 2007). In contrast to the aforementioned 
studies, the M line Tmod3–cyto-actin–sAnk1.5 complex lacks 
2-spectrin. Although the existence of Tmod–actin structures 
lacking spectrin has precedent in the lens (Woo et al., 2000), 
spectrin may be absent from the Tmod3–cyto-actin–sAnk1.5 
complex detected by co-IP because radioimmunoprecipitation 
assay (RIPA) buffer depolymerizes F-actin (unpublished data), 
thus eliminating 2-spectrin’s F-actin attachment points, leav-
ing only the proteins at the pointed ends of the filaments in the 
complex. Regardless, the sorting of cyto-actin and Tmods into 
extrasarcomeric SR microdomains identifies the SR as a new 
entry in the list of biological membrane systems whose archi-
tecture and physiology are regulated by Tmods.
Thus far, the molecular basis for the differential compart-
mentalization of sk-actin and cyto-actin with Tmods is unclear. 
These actins share 93% sequence identity; their little divergence 
is chiefly in their eight extreme N-terminal residues in actin 
subdomain I. Experiments using in vitro chemical cross-linking 
of Tmod3 and sk-actin identified residues on subdomains I and 
II of actin that directly interact with Tmod3 (Yamashiro et al., 
2010). Of these residues, D24, D25, E99, and E100 are in actin 
subdomain I and conserved in all actin isoforms, close to actin’s 
divergent extreme N terminus (Otterbein et al., 2001), which 
therefore might function as a cap mediator, either enhancing 
or inhibiting Tmod isoform binding to subdomain I. In muscle 
cells, the N terminus of cyto-actin might recruit Tmod3 to the 
SR cytoskeleton, whereas the N terminus of sk-actin might   
Figure 10.  Model of thin filament pointed end capping by Tmods and organization of the M line SR Tmod3–cyto-actin–sAnk1.5 complex in Tmod1
+/+Tg+ 
and Tmod1
/Tg+ muscle. In Tmod1
+/+Tg+ muscle, thin filament pointed ends are capped by a combination of Tmod1 and Tmod4, whereas Tmod3 is pre-
dominantly associated with the SR. In Tmod1
/Tg+ muscle, Tmod3 translocates from the SR to the thin filament pointed ends, destabilizing the Tmod3–cyto-
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anti–cyto-actin (A8481, 1:50; Sigma-Aldrich). Secondary antibodies and 
dilutions were as follows: Alexa Fluor 488–conjugated goat anti–rabbit IgG   
(1:200;  Invitrogen),  Alexa  Fluor  488–conjugated  donkey  anti–sheep 
IgG (1:200; Invitrogen), Alexa Fluor 568–conjugated goat anti–mouse   
IgG (1:200; Invitrogen), Alexa Fluor 647–conjugated goat anti–mouse IgG 
(1:200; Invitrogen), and Alexa Fluor 647–conjugated donkey anti–sheep 
IgG (1:200; Invitrogen).
For  Western  blotting,  the  primary  antibodies  and  dilutions  used 
were as follows: 0.01 µg/ml affinity-purified rabbit polyclonal anti–human 
Tmod1 (R1749), rabbit polyclonal antiserum to human Tmod3 (R5168bl3c, 
1:10,000), rabbit polyclonal antiserum to chicken Tmod4 preadsorbed 
by passage through a Tmod1 Sepharose column (R3577bl3c, 1:250),   
0.02  µg/ml  rabbit  polyclonal  anti–cyto-actin  (7577),  rabbit  polyclonal 
anti–-dystroglycan  (H-242,  1:1,000),  rabbit  polyclonal  anti-RyR1 
(AB9078, 1:1,000), rabbit polyclonal anti-Tm4 (AB5449, 1:1,000), 0.1 
µg/ml rabbit polyclonal anti-sAnk1.5 (ARP42566_T100), 0.044 µg/ml 
rabbit polyclonal anti–ankyrin-B, rabbit polyclonal anti-GST (Z-5, 1:1,000; 
Santa Cruz Biotechnology, Inc.), sheep polyclonal anti-Tm5NM1 (AB5447, 
1:1,000), mouse monoclonal anti–pan-actin (C4, 1:10,000; a gift from 
J.L. Lessard, University of Cincinnati, Cincinnati, OH), mouse monoclonal 
antidesmin (DE-U-10, 1:1,000), mouse monoclonal anti–2-spectrin (42/B, 
1:2,000), mouse monoclonal anti–-actin (HUC1-1, 1:1,000; Santa Cruz 
Biotechnology, Inc.), mouse monoclonal anti–cyto-actin (A8481, 1:1,000), 
mouse monoclonal anti-SERCA1 (VE121G9, 1:1,000), and mouse mono-
clonal antidystrophin (Dys2, 1:200). The secondary antibodies and di-
lutions  used  were  HRP-conjugated  donkey  anti–rabbit  IgG  (1:10,000; 
Invitrogen), HRP-conjugated donkey anti–mouse IgG (1:10,000; Invitrogen), 
HRP-conjugated goat anti–rabbit IgG (1:10,000; Invitrogen), and HRP- 
conjugated goat anti–mouse IgG (1:10,000; Invitrogen).
Immunofluorescence staining and confocal imaging
Mouse hindlimbs were pinned to cork, immersed in ice-cold relaxing buffer 
(100 mM NaCl, 2 mM KCl, 2 mM MgCl2, 6 mM K3PO4, 1 mM EGTA, and 
0.1% glucose, pH 7.0), relaxed for 24 h at 4°C, and then fixed for 24 h 
at 4°C in 4% PFA in relaxing buffer. TA and soleus muscles were then 
excised, cryoprotected in 20% sucrose in PBS, embedded in optimal cut-
ting temperature medium, and frozen on a metal block chilled in dry ice. 
Muscles  were  sectioned  into  12-µm-thick  cryosections  and  mounted  on 
slides. Sections were washed in PBS + 0.1% Triton X-100 (PBST), perme-
abilized for 15 min in PBS + 0.3% Triton X-100, and blocked for 2 h in 4% 
BSA + 1% goat and/or donkey sera in PBST. Tissues were labeled with pri-
mary antibodies diluted in blocking buffer overnight at 4°C, washed in 
PBST, and then labeled with a fluorophore-conjugated secondary antibody 
mixture in blocking buffer for 2 h at RT. The secondary antibody mixture 
was supplemented with Hoechst 33258 (1:200; Invitrogen) and either   
Alexa Fluor 647–phalloidin (1:100; Invitrogen) or rhodamine–phalloidin 
(1:100; Invitrogen) to stain nuclei and F-actin, respectively. Tissues were 
then washed again in PBST, preserved in Gel/Mount aqueous mounting 
medium (Sigma-Aldrich), and coverslipped.
Images of single optical sections were collected on a laser-scanning 
confocal microscope (Radiance 2100; Bio-Rad Laboratories) mounted on 
a TE2000-U microscope (Nikon) using a 100×/1.4 NA oil objective lens 
(zoom 1 or 3) at RT. LaserSharp 2000 software (Bio-Rad Laboratories) was 
used during image collection. The gain and laser power were adjusted to 
stay within the fluorescent detector’s linear range, and identical settings of 
the fluorescent imaging system were used to collect images of each set of 
stained sections from Tmod1
+/+Tg+ and Tmod1
/Tg+ animals. The ratios   
of M/Z or Z/P fluorescence were computed in ImageJ (National Institutes 
of Health) by placing a rectangular bounding box around three to five   
consecutive sarcomeres in a myofibril to generate a line scan, performing 
background correction using an adjacent myofibril-free region, and then 
integrating the areas under the fluorescence peaks corresponding to either 
the M line, Z line, or thin filament pointed ends. Fluorescence ratios were 
calculated from the grayscale single-channel TIFF images. To avoid error 
introduced by the nonlinearity of the fluorescence detector when collecting 
subthreshold or oversaturated signals, any myofibrils containing over- or 
underexposed pixels were excluded from the ratiometric analysis. Images 
were processed with Photoshop (Adobe), and image figures were con-
structed in Illustrator (Adobe).
Muscle sample preparation and Western blotting
For muscle fractionation experiments, TA muscles were dissected in ice-
cold relaxing buffer, relaxed for 24 h at 4°C, and homogenized with a 
Tissumizer (Teledyne Tekmar) in 10 vol of ice-cold rigor buffer (100 mM 
KCl, 2 mM MgCl2, 10 mM K3PO4, 1 mM EDTA, and 1 mM DTT, pH 7.0) 
supplemented with protease inhibitor cocktail (1:1,000; Sigma-Aldrich), 
extrasarcomeric cyto-actin has been thought to play a stabiliz-
ing and/or force-transmitting role at the sarcolemma (Craig   
and  Pardo,  1983;  Renley  et  al.,  1998;  Rybakova  et  al.,   
2000; Hanft et al., 2006, 2007). However, experiments involv-
ing  targeted  genetic  perturbation  of  cyto-actin  expression  in 
skeletal  muscle  have  produced  inconsistent  results.  Skeletal 
muscle–specific deletion of cyto-actin produces functional defi-
cits, corroborating a role in muscle function (Sonnemann et al., 
2006), but the deletion of cyto-actin from mdx muscle does not 
increase the severity of the mdx phenotype, which makes the 
surprising suggestion that the stabilization of the dystrophic 
sarcolemma by cyto-actin may actually be dispensable (Prins 
et al., 2008). Also surprising is that 2,000-fold overexpression 
of  cyto-actin  and  resultant  cyto-actin  incorporation  into  thin 
filaments do not appear to have any obvious effects on muscle 
structure or performance (Jaeger et al., 2009). SR defects and 
increased sarcomere misalignment arising from the absence of 
Tmod1, translocation of Tmod3, disruption of cyto-actin, and 
mislocalization  of  sAnk1.5  predict  that  outright  deletion  of 
cyto-actin might also produce a similar phenotype. Our data 
are the first to show that any actin-binding protein regulates   
SR-associated cyto-actin and sAnk1.5 in skeletal muscle and that 
this regulation stabilizes the SR and aligns adjacent myofibrils.   
Elucidation of cyto-actin dynamics, stability, and architecture in the 
context of its regulatory proteins may reconcile the inconsistent 
results of cyto-actin under- and overexpression experiments.
Materials and methods
Experimental animals
The embryonic lethality of Tmod1-null mice was previously rescued with a 
Tmod1 transgene controlled by the cardiac -MHC promoter (Tg(-MHC–
Tmod1), denoted as Tg+ in the text; McKeown et al., 2008). Tmod1-null 
mice with the Tg(-MHC–Tmod1) transgene express Tmod1 exclusively in 
the heart and in no other tissues and survive into adulthood (McKeown   
et al., 2008; Nowak et al., 2009; Gokhin et al., 2010; Moyer et al., 
2010).  In  immunofluorescence  and  whole-muscle  Western  blot  experi-
ments, 1-mo-old Tmod1
+/+Tg+ and Tmod1
/Tg+ mice were sacrificed by 
halothane inhalation followed by cervical dislocation. For TEM, 1- and   
6-mo-old mice were used. In muscle fractionation experiments, 6-mo-old 
mice were used. For Ca
2+ release assays, 9-mo-old mice were used. Geno-
typing was performed by PCR as previously described (McKeown et al., 
2008). All procedures were performed in accordance with animal care 
guidelines enforced by the Institutional Animal Care and Use Committee at 
The Scripps Research Institute.
Antibodies
For immunostaining, the primary antibodies and dilutions used were as 
follows:  1  µg/ml  affinity-purified  rabbit  polyclonal  anti–human  Tmod1 
(R1749),  rabbit  polyclonal  antiserum  to  human  Tmod3  (R5168bl3c, 
1:100),  rabbit  polyclonal  antiserum  to  chicken  Tmod4  preadsorbed 
by  passage  through  a  Tmod1  Sepharose  column  (R3577bl3c,  1:25),   
0.93  µg/ml  affinity-purified  rabbit  polyclonal  anti–cyto-actin  (7577;  a 
gift from J.M. Ervasti, University of Minnesota, Minneapolis, MN), rabbit 
polyclonal anti–-dystroglycan (H-242, 1:50; Santa Cruz Biotechnology, 
Inc.), rabbit polyclonal anti-RyR1 (AB9078, 1:100; Millipore), rabbit poly-
clonal anti-Tm4 (AB5449, 1:100; Millipore), 1 µg/ml rabbit polyclonal 
anti-sAnk1.5 (ARP42566_T100; Aviva Systems Biology), 4.4 µg/ml rabbit 
polyclonal anti–ankyrin-B (a gift from V. Bennett, Duke University, Durham, 
NC; Mohler et al., 2005), rabbit polyclonal antiobscurin (IQ-54, 1:100; a 
gift from S. Lange, University of California, San Diego, La Jolla, CA), sheep 
polyclonal anti-Tm5NM1 (AB5447, 1:100; Millipore), mouse monoclonal 
anti–2-spectrin  (42/B,  1:200;  BD),  mouse  monoclonal  anti-SERCA1 
(VE121G9, 1:100; Santa Cruz Biotechnology, Inc.), mouse monoclonal 
antidystrophin (Dys2, 1:20; Millipore), mouse monoclonal antidesmin   
(DE-U-10, 1:100; Santa Cruz Biotechnology, Inc.), and mouse monoclonal JCB • VOLUME 194 • NUMBER 1 • 2011   118
at 1,000 g for 5 min, and the resulting supernatant (unbound fraction) 
was mixed with an equal volume of 2× SDS sample buffer. The beads 
were  then  washed  three  times,  and  the  resulting  pellet  (bound  frac-
tion) was solubilized in an equal volume of 2× SDS sample buffer and 
clarified by centrifugation at 1,000 g for 5 min. Protein samples were   
then  subjected  to  SDS-PAGE  and  either  Coomassie  blue  staining  or 
Western blotting, as described in the Muscle sample preparation and 
Western blotting section.
TEM
Mice were perfusion fixed in 4% PFA + 1.5% glutaraldehyde in 0.1 M 
cacodylate buffer on ice followed by dissection of soleus and EDL muscles 
and incubation for several hours in the same fixative. Fixation was contin-
ued overnight in 2.5% glutaraldehyde in 0.1 M cacodylate buffer, and tis-
sues were washed in cacodylate buffer, fixed further in 1% OsO4 in 0.1 M 
sodium cacodylate buffer for 2 h, again washed in cacodylate buffer, and 
then dehydrated in graded ethanols followed by propylene oxide and 
embedded in EMbed 812/Araldite (Electron Microscopy Sciences). Thick 
sections (1–2 µm) were cut, mounted on glass slides, and stained in tolu-
idine blue for assessment of tissue structure and preservation on a light   
microscope. Subsequently, 60-nm thin sections were cut, mounted on copper 
slot grids coated with parlodion, and stained with uranyl acetate and 
lead citrate for examination on a transmission electron microscope (Philips 
CM100; FEI) at 80 kV. Images were collected using a charge-coupled 
device camera (Megaview III; Olympus).
Ca
2+ release assay
TA muscles were dissected in PBS, and tendons and connective tissue were 
carefully removed. Muscles were rinsed thoroughly in PBS, and extracellular 
collagen was digested by gently agitating muscles in 5 vol of 1 mg/ml col-
lagenase in Eagle’s minimal essential medium for 2 h at 37°C. Muscle   
fibers were then dissociated by repeated pipette aspiration. The fiber   
suspension was added to a solution of ACh (Sigma-Aldrich) in minimal es-
sential medium, which was serially diluted from 0.005 M to 5 × 10
12 M 
on a 96-well plate. ACh-induced Ca
2+ flux from the SR was measured using 
a Fluo-4 Direct assay kit (Invitrogen) according to the manufacturer’s in-
structions. A plate reader quantified the results of the assay at excitation 
and emission wavelengths of 494 and 516 nm, respectively. The increase 
in Ca
2+ flux from the baseline was normalized to baseline (Ca/Ca
0) and 
plotted as a function of ACh concentration.
Statistics
A reanalysis of previously published data (Gokhin et al., 2010) revealed 
that the intraanimal muscle functional variability is as large as the inter-
animal variability. Thus, muscles from hindlimbs of the same animal were 
treated as independent samples. The normal distribution of data was 
evaluated using the Shapiro-Wilk test. Where appropriate, differences 
between genotype-dependent parameters were detected using the Stu-
dent’s t test. Data are presented as mean ± SD, and statistical signifi-
cance was defined as P < 0.05. Statistical analysis was performed in 
Excel (Microsoft).
Online supplemental material
Fig. S1 demonstrates the specificities of our actin isoform–specific anti-
bodies. Fig. S2 depicts the Z line–flanking localization of Tmod4. Fig. S3   
shows that the deletion of Tmod1 does not alter the levels of extra-
sarcomeric cytoskeletal proteins. Fig. S4 shows that the deletion of Tmod1 
does not alter the localization of ankyrin-B or obscurin. Fig. S5 shows 
negative  controls  for  co-IP  experiments  showing  that  the  deletion  of 
Tmod1 disrupts the Tmod3–cyto-actin–sAnk1.5 complex. Online supple-
mental  material  is  available  at  http://www.jcb.org/cgi/content/full/ 
jcb.201011128/DC1.
We gratefully acknowledge Roberta B. Nowak for managing mouse breeding 
and  for  assistance  with  confocal  microscopy,  Malcolm  R.  Wood  for  EM, 
Nancy E. Kim for assistance with Western blotting, Joanna L. Thomas for cultur-
ing hUVECs, Sawako Yamashiro for purifying recombinant Tmods, and Ciara 
Kamahele-Sanfratello for mouse genotyping. Members of the Fowler labora-
tory provided numerous helpful discussions.
This work was supported by National Institutes of Health grant R01-
HL083464 (to V.M. Fowler) and National Heart, Lung, and Blood Institute 
vascular biology training grant T32-HL007195-34 (to D.S. Gokhin).
Submitted: 24 November 2010
Accepted: 7 June 2011
as previously described (Knight and Trinick, 1982; Fowler et al., 1993). 
The homogenate was centrifuged at 1,500 g for 5 min at 4°C, producing 
a low-speed pellet rich in myofibrils. After washing the low-speed pellet 
four times in rigor buffer, the low-speed supernatant was centrifuged at 
15,000 g for 15 min at 4°C, producing a medium-speed pellet rich in 
organelles, membranes, and other extrasarcomeric structures. The result-
ing medium-speed supernatant was then centrifuged at 150,000 g for 15 
min at 4°C, producing a high-speed pellet rich in microsomes and macro-
molecular complexes and a high-speed supernatant containing cytosol. Pel-
lets were solubilized by sonication in 2× SDS sample buffer and by boiling 
for 5 min. Total homogenate and cytosol were solubilized by vortexing in 
2× SDS sample buffer and by boiling for 5 min. For sample preparation 
without fractionation, EDL muscles were dissected and extracted by homog-
enization in 4 vol (volume/wet weight) of 9.2 M urea and solubilized in 
1/5 vol of 5× SDS sample buffer and by boiling for 5 min. Human eryth-
rocyte Mg
2+ ghosts (Fowler and Bennett, 1984) and human umbilical vein 
endothelial cells (hUVECs) were solubilized by vortexing in 2× SDS sample 
buffer and by boiling for 5 min.
Proteins were separated via SDS-PAGE on 14% minigels and trans-
ferred to nitrocellulose in transfer buffer with 20% methanol at 4°C. For 
2-spectrin, RyR1, and dystrophin blots, 8% minigels, 4–10% linear gradi-
ent minigels, and 4–15% linear gradient minigels were used, respectively, 
and proteins were transferred without methanol in 0.01% SDS (Nowak   
et al., 2009). For muscle fractionation, co-IP, and GST pull-down experi-
ments, 4–20% linear gradient minigels were used. Blots were stained with 
0.2% Ponceau S in 3% TCA to verify protein transfer, incubated in Blitz 
buffer (4% BSA, 10 mM NaHPO4, pH 7.4, 150 mM NaCl, 1 mM EDTA, 
and 0.2% Triton X-100) for at least 2 h at RT, and then incubated in pri-
mary antibodies diluted in Blitz overnight at 4°C. After washing in PBST, 
blots were incubated in either HRP-conjugated Protein A (1:10,000; Sigma-
Aldrich) or HRP-conjugated secondary antibodies diluted in Blitz + 2% 
donkey serum for 1–2 h at RT. After washing again in PBST, protein bands 
were detected using ECL. Blots were exposed for a series of times (1 s– 
5 min), followed by scanning, densitometry, and quantification using ImageJ. 
Only blots with intermediate exposures on the linear region of the signal 
intensity versus the exposure time curve were used thereafter. When ap-
propriate, blots were controlled for loading by stripping and reprobing for 
total actin, using the same detection procedure. For muscle fractionation 
experiments, distributions were computed by expressing the intensities of 
the 1,500-g pellet, 15,000-g pellet, 150,000-g pellet, and cytosol bands 
as percentages of the sum of the intensities of all four bands.
co-IP
Mouse skeletal muscles were dissected in ice-cold PBS, homogenized 
with a Tissumizer in 10 vol of ice-cold RIPA buffer (150 mM NaCl, 1% 
NP-40, 0.5% sodium deoxycholate, 0.1% SDS, and 50 mM Tris-HCl, 
pH 8.0) supplemented with protease inhibitor cocktail (1:1,000), and 
clarified by 5 min of centrifugation at 1,500 g to remove myofibrils. The 
resulting SR-enriched extract was divided into 1-ml aliquots, to which 
one of the following was added: 2 µg rabbit polyclonal anti-sAnk1.5 
(ARP42566_T100), 2 µg rabbit polyclonal anti–human Tmod1 (R1749), 
5 µl rabbit polyclonal antiserum to human Tmod3 (R5168bl3c), 2 µg 
of preimmune control IgG, or 5 µl of preimmune control serum. Anti-
body-bound protein complexes were absorbed to 100 µl MACS Pro-
tein A–conjugated super-paramagnetic MicroBeads (Miltenyi Biotec) and 
incubated for 30 min on ice, followed by passage through a Column 
(Miltenyi Biotec) using a MACS magnetic separator (Miltenyi Biotec). 
Beads were washed with RIPA buffer and eluted with 100 µl of 1× SDS 
sample buffer according to the manufacturer’s instructions. The input 
extract (diluted in 2× SDS sample buffer) and eluted immunoprecipitates 
were then subjected to SDS-PAGE and Western blotting, as described in 
the previous section.
GST pull-down assay
An excess (20 µl) of ProCatch glutathione resin (Miltenyi Biotec) was 
prewashed in binding buffer (20 mM Hepes, 60 mM NaCl, 0.5 mM 
EDTA, 1 mM NaN3, and 0.1% Tween 20, pH 7.3), and 3 µg of either 
GST or GST-sAnk1.5 (a gift from M.A. Ackermann and R.J. Bloch, Uni-
versity of Maryland School of Medicine, Baltimore, MD; Borzok et al., 
2007) was loaded onto the resin by incubation for 1 h at 4°C. The 
beads were then washed three times by centrifugation at 1,000 g for 
5 min, decanting the resulting supernatant, and resuspension in 1 ml of 
fresh binding buffer. Next, 3 µg of purified recombinant human Tmod1 
or Tmod3 (Yamashiro et al., 2010) was added for a final concentration 
of 3 µg/ml Tmod and incubated for 1 h at 4°C. The beads were centrifuged 119 Tropomodulins in the sarcoplasmic reticulum • Gokhin and Fowler
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